NF1-Associated PN Community Insights: Key Questions, Expert Answers
This 30-minute live social event features two expert faculty members leading an interactive discussion focused on the care of patients with neurofibromatosis…
Related Articles
RP1 Plus Nivolumab Is Active, Safe in Advanced Melanoma After Progression on AntiβPD-1 Therapy
RP1 plus nivolumab generated responses in advanced melanoma that progressed on or after prior antiβPD-1 therapy.
An Overview of HER2 Alterations in NSCLC and Implications for Treatment
Panelists discuss how understanding the distinctions between HER2 overexpression and mutations in NSCLC influences patient care strategies and prognosis, alongside the challenges of biomarker testing…
PRRT Plus Pembrolizumab Confers Durable Disease Control in Well-Differentiated NETs
PRRT and pembrolizumab provided durable disease control in a trial of patients with well-differentiated NETs.
IMA203 Produces Responses in Heavily Pretreated Advanced Melanoma, Other Solid Tumors
The investigational PRAME-targeted T-cell therapy IMA203 generated responses in melanoma and other solid tumors,
Unleashing the Power of Automation in Enterprise Communication
Interested in being a guest? Email us at admin@evankirstel.com (https://www.buzzsprout.com/twilio/text_messages/2228835/open_sms) Ever wondered how the integ…
Advances in oncolytic immunotherapy for melanoma: vusolimogene oderparepvec
Gino In, MD, University of Southern California, Los Angeles, CA, comments on the potential of oncolytic immunotherapies for the treatment of advanced melanoma. The Phase…
Tandem Meetings Home
The Tandem Meetings are a premier event in the evolving hematopoietic cell transplantation (HCT) and cellular therapy field. Through the scientific program, attendees gain access…
Donate to American Association for Cancer Research – 2024 Philadelphia Marathon Weekend β
2024 Philadelphia Marathon Weekend 2600 Benjamin Franklin Pkwy, Philadelphia, PA 19130 – Philadelphia Marathon WeekendNovember 22-24, 2024Theβ¦ – November 23, 2024
The Truth About RFK Jr. (And Dr. Oz!) w/Dr. Paul Offit
Never underestimate the forces of delusion (on ALL sides). Vaccine co-inventor Paul Offit returns to spit some fire about RFK Jr. and Dr. Oz, pandemic…
Affordable Care Act May Increase Access to Colon Cancer Care : Oncology Times
An abstract is unavailable.
